← Back
$AUPH All transactions

Aurinia Pharmaceuticals Inc.

F

$ Value

$644K

Shares

40,385

Price

$16

Filed

Jan 5

Insider

Name

Robertson Stephen P.

Title

EVP, General Counsel

CIK

0001837798

Roles

Officer

Transaction Details

Transaction Date

2026-01-02

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

517,934

Footnotes

Represents the number of shares earned upon certification of performance for a performance award payable solely in common shares of the Issuer that vest in two (2) equal annual installments on December 31, 2025 and December 31, 2026. | Represents shares withheld to satisfy tax withholding obligations upon the vesting of performance awards. | Includes common shares acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 531 common shares were acquired on May 30, 2025 and 354 common shares were acquired on November 28, 2025.

Filing Info

Accession No.

0001600620-26-000005

Form Type

4

Issuer CIK

0001600620

Robertson Stephen P.'s History

Date Ticker Type Value
2026-03-02 AUPH F $519K
2026-02-27 AUPH A $0
2026-02-27 AUPH A $0
2026-02-20 AUPH F $499K
2026-01-02 AUPH A $0
2026-01-02 AUPH F $644K

Other Insiders at AUPH (90d)

Insider Bought Sold Last
TANG KEVIN $12.7M 2026-03-03
Greenleaf Peter
Chief Executive Officer
2026-03-02
Donley Matthew Maxwell
Chief Operating Officer
2026-03-02
Miller Joseph M
Chief Financial Officer
2026-03-02
Robertson Stephen P.
EVP, General Counsel
2026-03-02
Keenan Greg
SVP, Chief Medical Officer
2026-03-06